Individualized homoeopathic medicines in managing pain of tennis elbow: Double-blind, randomized, placebo-controlled trial

The Calcutta Homoeopathic Medical College and Hospital0 sites55 target enrollmentStarted: TBDLast updated: September 18, 2023

Trial Snapshot

No summary available.

•1. Patients aged between 18 and 65 years
•2. Patients of either sex
•3. Suffering from tennis elbow – experiencing lateral elbow pain for 12 weeks or more, pain with resisted wrist extension, and tenderness on palpation over lateral epicondyle
•4. Patients who are literate, able to read Bengali or English, capable of filling the questionnaire and providing with written informed consent

•1. Patients with previous trauma and/or undergone surgery of the elbow region
•2. Patients who are undergoing treatment with NSAIDS during 4 weeks prior to enrolment in the study
•3. Elbow pain due to peripheral nerve entrapment, cervical radiculopathy
•4. Corticosteroid injection within 6 months
•5. Vulnerable population – unconscious, ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent
•6. Unstable mental or psychiatric illness or other systemic diseases (e.g., uncontrolled hypertension, diabetes, thyroid diseases etc.) affecting quality of life or any vital organ failure
•7. Currently receiving homoeopathic treatment for any chronic condition(s)
•8. Self-reported immune-compromised state
•9. Pregnant and puerperal women, lactating mothers
•10.Patients with habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence

Sponsor

The Calcutta Homoeopathic Medical College and Hospital